KR20040071143A - 의료 또는 진단 절차에 사용하기 위한 조성물 - Google Patents

의료 또는 진단 절차에 사용하기 위한 조성물 Download PDF

Info

Publication number
KR20040071143A
KR20040071143A KR10-2004-7007813A KR20047007813A KR20040071143A KR 20040071143 A KR20040071143 A KR 20040071143A KR 20047007813 A KR20047007813 A KR 20047007813A KR 20040071143 A KR20040071143 A KR 20040071143A
Authority
KR
South Korea
Prior art keywords
composition
imaging
natural
stabilizer
anatomical site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR10-2004-7007813A
Other languages
English (en)
Korean (ko)
Inventor
토마스 씨. 로엔스타인
조르그 에프. 데바틴
허베르트 슈니만
Original Assignee
이-지-이엠, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이-지-이엠, 인코포레이티드 filed Critical 이-지-이엠, 인코포레이티드
Publication of KR20040071143A publication Critical patent/KR20040071143A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
KR10-2004-7007813A 2001-11-21 2002-11-21 의료 또는 진단 절차에 사용하기 위한 조성물 Ceased KR20040071143A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33207401P 2001-11-21 2001-11-21
PCT/US2002/037385 WO2003045308A2 (en) 2001-11-21 2002-11-21 Formulations for use in medical or diagnostic procedures

Publications (1)

Publication Number Publication Date
KR20040071143A true KR20040071143A (ko) 2004-08-11

Family

ID=23296624

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2004-7007813A Ceased KR20040071143A (ko) 2001-11-21 2002-11-21 의료 또는 진단 절차에 사용하기 위한 조성물

Country Status (11)

Country Link
US (2) US7427391B2 (https=)
EP (1) EP1458328B1 (https=)
JP (1) JP4820054B2 (https=)
KR (1) KR20040071143A (https=)
AU (1) AU2002365395B2 (https=)
BR (1) BR0214314A (https=)
CA (1) CA2466808C (https=)
IL (1) IL162095A0 (https=)
RU (1) RU2004119035A (https=)
WO (1) WO2003045308A2 (https=)
ZA (1) ZA200404023B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7427391B2 (en) * 2001-11-21 2008-09-23 E-Z-Em, Inc. Formulations for use in medical and diagnostic procedures
US7378081B2 (en) * 2003-01-29 2008-05-27 Vincon Research Enterprises, Llc Composition and method for direct visualization of the human appendix
US20050180920A1 (en) * 2003-01-29 2005-08-18 Vincenzo Giuliano Oral contrast media composition for computerized axial tomographic examinations and method
CN100388313C (zh) * 2003-02-05 2008-05-14 皇家飞利浦电子股份有限公司 定量分析精度指示
US7582283B2 (en) * 2004-02-13 2009-09-01 Wisconsin Alumni Research Foundation Contrast agents to improve gastrointestinal tract opacification during abdominal and pelvic CT scans
ES2331195T3 (es) 2004-07-15 2009-12-23 Gynaecologiq B.V. Composicion y metodo para imagineria medica de cavidades corporales.
US9585973B1 (en) * 2008-06-05 2017-03-07 Peter Quagliano Palatable liquid dilution vehicles for oral contrast agents
NL2003660C2 (en) 2009-10-16 2011-04-19 Giskit B V Composition and method for medical imaging of body cavities.
WO2011136336A1 (ja) * 2010-04-30 2011-11-03 味の素株式会社 Ｃｔコロノグラフィに用いられる経口投与用液剤及び消化管造影用組成物
AU2019227840B2 (en) * 2018-02-27 2022-12-15 Trisco ICAP Pty Ltd An ingredient
IT201900003113A1 (it) * 2019-03-04 2020-09-04 Azienda Ospedaliero Univ Policlinico S Orsola Malpighi Bologna Bevanda coadiuvante
US11730831B2 (en) 2019-03-26 2023-08-22 Sicreations, Llc Imaging agents and methods of using the same
US11833227B2 (en) 2019-05-29 2023-12-05 Sicreations, Llc Methods for preserving a subject and using imaging contrast agents

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB657979A (en) * 1948-07-03 1951-10-03 Miles Lab Improvements in or relating to x-ray contrast mediums
US3975512A (en) * 1970-12-21 1976-08-17 University Of Illinois Foundation Non-toxic brominated perfluorocarbons radiopaque agents
US4074709A (en) * 1976-04-15 1978-02-21 Kaplan Leopold S Method and device for facilitating double-contrast studies of the upper gastrointestinal tract
GB1599881A (en) * 1977-02-02 1981-10-07 Millington A R Preparation for diagnostic radiology
US4448207A (en) * 1981-11-03 1984-05-15 Vital Metrics, Inc. Medical fluid measuring system
SE8601563D0 (sv) * 1986-04-08 1986-04-08 Carbomatrix Ab Matrismaterial, forfarande for framstellning derav och anvendning derav
US5019059A (en) * 1986-12-15 1991-05-28 Uresil Corporation Apparatus and method for collecting body fluids
US4930997A (en) * 1987-08-19 1990-06-05 Bennett Alan N Portable medical suction device
AU4492989A (en) * 1988-10-20 1990-05-14 Fusen H. Chen Incontinence device
US5783171A (en) * 1989-06-16 1998-07-21 Neorx Corporation Radionuclide metal N2 S2 chelates substituted with glucose and biotin moieties
GB8916782D0 (en) * 1989-07-21 1989-09-06 Nycomed As Compositions
US4957486A (en) * 1989-10-02 1990-09-18 Davis Emsley A Rectal-stomal insert apparatus and method
US6088613A (en) 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
US5368840A (en) * 1990-04-10 1994-11-29 Imarx Pharmaceutical Corp. Natural polymers as contrast media for magnetic resonance imaging
US5107842A (en) * 1991-02-22 1992-04-28 Molecular Biosystems, Inc. Method of ultrasound imaging of the gastrointestinal tract
US5179955A (en) 1991-02-22 1993-01-19 Molecular Biosystems, Inc. Method of abdominal ultrasound imaging
JP3238485B2 (ja) * 1992-08-07 2001-12-17 明治乳業株式会社 消化管造影用組成物
US5380522A (en) 1992-08-11 1995-01-10 Day; Charles E. Method for treatment of irritable bowel syndrome
EP0669823A4 (en) * 1992-10-06 1996-03-13 Molecular Biosystems Inc Ultrasound imaging of body cavity.
JPH06157355A (ja) * 1992-11-13 1994-06-03 Dai Ichi Seiyaku Co Ltd Ｍｒｉ用粒状製剤
EP0741581A1 (en) * 1994-01-28 1996-11-13 Nycomed Imaging As Oral magnetic particle formulation
US5611342A (en) * 1994-02-15 1997-03-18 Molecular Biosystems, Inc. Method of computer tomography imaging the gastrointestinal tract and surrounding upper abdominal tissues and organs using an orally administered low density contrast medium
US5736121A (en) 1994-05-23 1998-04-07 Imarx Pharmaceutical Corp. Stabilized homogenous suspensions as computed tomography contrast agents
DE4424233C1 (de) * 1994-07-09 1995-12-07 Thomas Gieselmann Orales Echokontrastmittel für Ultraschalldiagnostik
US5782762A (en) * 1994-10-27 1998-07-21 Wake Forest University Method and system for producing interactive, three-dimensional renderings of selected body organs having hollow lumens to enable simulated movement through the lumen
US6066139A (en) * 1996-05-14 2000-05-23 Sherwood Services Ag Apparatus and method for sterilization and embolization
US5779662A (en) * 1996-05-20 1998-07-14 Linvatec Corporation Laparoscopic tissue resection system
JP2002511837A (ja) * 1996-09-10 2002-04-16 メデイノックス，インコーポレイテッド ポリジチオカルバメート含有マクロ分子と、治療及び診断用途へのその使用
EP0959693A1 (en) * 1997-01-31 1999-12-01 Fmc Corporation Texture and stabilizer composition
GB9710699D0 (en) * 1997-05-24 1997-07-16 Danbiosyst Uk Gastro-retentive controlled release system
CN1233505A (zh) * 1998-04-24 1999-11-03 胡挽华 一种胃肠阴性造影剂及其生产方法
US6214376B1 (en) * 1998-08-25 2001-04-10 Banner Pharmacaps, Inc. Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture
JP3099293B2 (ja) * 1999-02-12 2000-10-16 イトー海外事業株式会社 可食印刷用シート及びその製造装置並びに製造方法
JP2001048810A (ja) * 1999-08-04 2001-02-20 Ina Food Ind Co Ltd 造影剤用増粘剤
IN192748B (https=) * 2000-08-29 2004-05-15 Ranbaxy Lab Ltd
IL155204A0 (en) * 2000-10-02 2003-11-23 Arizeke Pharmaceuticals Inc Compositions and methods for the transport of biologically active agents across cellular barriers
KR20040032918A (ko) 2001-08-16 2004-04-17 더 스테이트 오브 오레곤 액팅 바이 앤드 쓰루 더 스테이트 보드 오브 하이어 에쥬케이션 온 비해프 오브 오레곤 스테이트 유니버시티 팽창 가능한 위 정지 장치
US7427391B2 (en) * 2001-11-21 2008-09-23 E-Z-Em, Inc. Formulations for use in medical and diagnostic procedures

Also Published As

Publication number Publication date
AU2002365395B2 (en) 2006-07-20
EP1458328B1 (en) 2013-01-30
US7427391B2 (en) 2008-09-23
JP2005510531A (ja) 2005-04-21
JP4820054B2 (ja) 2011-11-24
IL162095A0 (en) 2005-11-20
US20090180963A1 (en) 2009-07-16
WO2003045308A3 (en) 2003-12-18
CA2466808C (en) 2009-01-27
EP1458328A2 (en) 2004-09-22
EP1458328A4 (en) 2009-06-17
BR0214314A (pt) 2004-11-09
RU2004119035A (ru) 2005-11-20
WO2003045308A2 (en) 2003-06-05
US20040241093A1 (en) 2004-12-02
CA2466808A1 (en) 2003-06-05
US8343462B2 (en) 2013-01-01
AU2002365395A1 (en) 2003-06-10
ZA200404023B (en) 2005-05-24

Similar Documents

Publication Publication Date Title
US8343462B2 (en) Formulations for use in medical and diagnostic procedures
Rao et al. Diagnosis and management of chronic constipation in adults
Lauenstein et al. Optimization of oral contrast agents for MR imaging of the small bowel
US20090136426A1 (en) Contrast media for using in medical and diagnostic procedures and methods of using the same
JP2005510531A5 (https=)
Lohan et al. MR small bowel enterography: optimization of imaging timing
US20260102522A1 (en) Low x-ray attenuation change hard shelled oral contrast material
Berther et al. Comparison of neutral oral contrast versus positive oral contrast medium in abdominal multidetector CT
Borthne et al. Osmolarity: a decisive parameter of bowel agents in intestinal magnetic resonance imaging
US7582283B2 (en) Contrast agents to improve gastrointestinal tract opacification during abdominal and pelvic CT scans
Vikram et al. Comparison of mannitol and meglumine diatrizoate for stomach and small bowel wall study by computed tomography, a prospective study
Tuñón et al. Contrast agents for MR enterography
Lee et al. Comparison of static-fluid or excretory magnetic resonance urography with computed tomography urography for visualization of nondilated renal pelvises and ureters in healthy Beagles
Shi et al. Magnesium sulfate as an oral contrast medium in magnetic resonance imaging of the small intestine
Naik et al. Evaluation of bowel by computed tomography enterography: comparing the water, mannitol and iodinated oral contrast
SU1156641A1 (ru) Способ рентгенологического исследовани органов гепатодуоденопанкреатической области
Oh-oka et al. Usefulness of MR-seminography using Gd-DTPA in intermediate magnetic field MRI equipment

Legal Events

Date Code Title Description
A201 Request for examination
PA0105 International application

Patent event date: 20040521

Patent event code: PA01051R01D

Comment text: International Patent Application

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20051209

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20060404

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20051209

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I